nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

15.07.2023 | Research

Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma

verfasst von: Liemei Lv, Yu Zhang, Ran Kong, Cong Wang, Xin Wang, Xiangxiang Zhou

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 14/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Emerging evidence suggests that pyroptosis plays an essential role in the development and progression of multiple cancers. However, the role of pyroptosis remains elusive in diffuse large B-cell lymphoma (DLBCL).

Methods

The expression profile data of DLBCL and normal samples of pyroptosis-related genes (PRGs) were analyzed, and the clinical characteristics of DLBCL patients were further investigated. A prognostic model was established using LASSO-Cox regression analysis. The expression of these PRGs was validated by qRT-PCR in DLBCL cell lines. Cell proliferation assay and flow cytometry were utilized to explore the impact of pyroptosis inhibitor (disulfiram, DSF) combined with PD1/PD-L1 inhibitor (BMS1166) on DLBCL cell proliferation.

Results

Most PRGs were dysregulated in DLBCL samples and associated with overall survival (OS). Six PRGs were selected to construct a prognostic risk score model. The qRT-PCR analysis revealed that CASP8, CASP9, NLRP1, NLRP6, and TIRAP are downregulated, while SCAF11 was significantly upregulated in DLBCL cell lines. This prognostic model divided DLBCL patients into low-risk and high-risk groups. Patients in the low-risk group exhibited lower mortality and longer OS than those in the high-risk group. The ROC curve and nomogram demonstrated this model's excellent predictive performance. GO and KEGG enrichment indicated that the differentially expressed genes (DEGs) between subgroups were associated with cellular protein modification processes and JAK-STAT signaling pathway regulation. Moreover, the risk score was correlated with the immune profile. Cell proliferation assay and flow cytometry further validated the synergistic anti-tumor effects of DSF and BMS1166 on DLBCL cells.

Conclusion

In summary, we developed a comprehensive prognostic model based on PRGs characteristics, which accurately predicted the prognosis of DLBCL patients. Pyroptosis-targeting coupled with immunotherapies would be a promising therapeutic strategy for DLBCL.

Nur mit Berechtigung zugänglich

Aglietti RA, Dueber EC (2017) Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. Trends Immunol 38:261–271. https://doi.org/10.1016/j.it.2017.01.003CrossRefPubMed

Ahechu P et al (2018) NLRP3 inflammasome: a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development. Front Immunol 9:2918. https://doi.org/10.3389/fimmu.2018.02918CrossRefPubMedPubMedCentral

Bagratuni T et al (2016) TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma. Br J Haematol 172:44–47. https://doi.org/10.1111/bjh.13786CrossRefPubMed

Blasco MT, Gomis RR (2020) PD-L1 controls cancer pyroptosis. Nat Cell Biol 22:1157–1159. https://doi.org/10.1038/s41556-020-00582-wCrossRefPubMed

Carpio C et al (2020) Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. Blood 135:996–1007. https://doi.org/10.1182/blood.2019002395CrossRefPubMedPubMedCentral

Chu Y, Zhou X, Wang X (2021) Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. J Hematol Oncol. https://doi.org/10.1186/s13045-021-01097-zCrossRefPubMedPubMedCentral

de Vos S et al (2014) A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. J Hematol Oncol 7:44. https://doi.org/10.1186/1756-8722-7-44CrossRefPubMedPubMedCentral

Du T et al (2021) Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med 11:e492. https://doi.org/10.1002/ctm2.492CrossRefPubMedPubMedCentral

Erkes DA et al (2020) Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis. Cancer Discov 10:254–269. https://doi.org/10.1158/2159-8290.CD-19-0672CrossRefPubMed

Finger JN et al (2012) Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. J Biol Chem 287:25030–25037. https://doi.org/10.1074/jbc.M112.378323CrossRefPubMedPubMedCentral

Fritsch M et al (2019) Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575:683–687. https://doi.org/10.1038/s41586-019-1770-6CrossRefPubMed

Fu XW, Song CQ (2021) Identification and validation of pyroptosis-related gene signature to predict prognosis and reveal immune infiltration in hepatocellular carcinoma. Front Cell Dev Biol 9:748039. https://doi.org/10.3389/fcell.2021.748039CrossRefPubMedPubMedCentral

Gao C et al (2020) Autophagy Activation Represses Pyroptosis through the IL-13 and JAK1/STAT1 Pathways in a Mouse Model of Moderate Traumatic Brain Injury. ACS Chem Neurosci 11:4231–4239. https://doi.org/10.1021/acschemneuro.0c00517CrossRefPubMed

Hou J et al (2020) PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol 22:1264–1275. https://doi.org/10.1038/s41556-020-0575-zCrossRefPubMedPubMedCentral

Hu B et al (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 107:21635–21640. https://doi.org/10.1073/pnas.1016814108CrossRefPubMedPubMedCentral

Jorgensen I, Miao EA (2015) Pyroptotic cell death defends against intracellular pathogens. Immunol Rev 265:130–142. https://doi.org/10.1111/imr.12287CrossRefPubMedPubMedCentral

Karki R, Kanneganti TD (2019) Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer 19:197–214. https://doi.org/10.1038/s41568-019-0123-yCrossRefPubMedPubMedCentral

Keane C et al (2020) LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma. Blood Adv 4:1367–1377. https://doi.org/10.1182/bloodadvances.2019001390CrossRefPubMedPubMedCentral

Kemper K, Rodermond H, Colak S, Grandela C, Medema JP (2012) Targeting colorectal cancer stem cells with inducible caspase-9. Apoptosis 17:528–537. https://doi.org/10.1007/s10495-011-0692-zCrossRefPubMedPubMedCentral

Kennedy CL et al (2014) Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis. Oncogene 33:2540–2546. https://doi.org/10.1038/onc.2013.205CrossRefPubMed

Kovacs SB, Miao EA (2017) Gasdermins: effectors of pyroptosis. Trends Cell Biol 27:673–684. https://doi.org/10.1016/j.tcb.2017.05.005CrossRefPubMedPubMedCentral

Lee S, Hirohama M, Noguchi M, Nagata K, Kawaguchi A (2018) Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through the type i interferon signaling pathway in a mutually exclusive manner. J Virol 92 https://doi.org/10.1128/JVI.00396-18

Lesokhin AM et al (2016) Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. J Clin Oncol 34:2698–2704. https://doi.org/10.1200/JCO.2015.65.9789CrossRefPubMedPubMedCentral

Liu Y, Zhou X, Wang X (2021) Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol 14:125. https://doi.org/10.1186/s13045-021-01134-xCrossRefPubMedPubMedCentral

Mandal R, Barron JC, Kostova I, Becker S, Strebhardt K (2020) Caspase-8: the double-edged sword. Biochim Biophys Acta Rev Cancer 1873:188357. https://doi.org/10.1016/j.bbcan.2020.188357CrossRefPubMed

Miao Y, Medeiros LJ, Li Y, Li J, Young KH (2019) Genetic alterations and their clinical implications in DLBCL. Nat Rev Clin Oncol 16:634–652. https://doi.org/10.1038/s41571-019-0225-1CrossRefPubMed

Normand S et al (2011) Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA 108:9601–9606. https://doi.org/10.1073/pnas.1100981108CrossRefPubMedPubMedCentral

Pages F et al (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29:1093–1102. https://doi.org/10.1038/onc.2009.416CrossRefPubMed

Pascual M et al (2019) PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. Blood 133:2401–2412. https://doi.org/10.1182/blood.2018889931CrossRefPubMedPubMedCentral

Qiao L et al (2019) alpha-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway. FASEB J 33:12760–12767. https://doi.org/10.1096/fj.201900483RRCrossRefPubMed

Salcedo R et al (2010) MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 207:1625–1636. https://doi.org/10.1084/jem.20100199CrossRefPubMedPubMedCentral

Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384:842–858. https://doi.org/10.1056/NEJMra2027612CrossRefPubMedPubMedCentral

Swerdlow SH et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375–2390. https://doi.org/10.1182/blood-2016-01-643569CrossRefPubMedPubMedCentral

Tang R et al. (2020) Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol 13 https://doi.org/10.1186/s13045-020-00946-7

Topalian SL, Taube JM, Anders RA, Pardoll DM (2016) Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 16:275–287. https://doi.org/10.1038/nrc.2016.36CrossRefPubMedPubMedCentral

Tsuchiya K (2021) Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity. Int J Mol Sci. https://doi.org/10.3390/ijms22010426CrossRefPubMedPubMedCentral

Tummers B, Green DR (2017) Caspase-8: regulating life and death. Immunol Rev 277:76–89. https://doi.org/10.1111/imr.12541CrossRefPubMedPubMedCentral

Vande Walle L, Lamkanfi M (2016) Pyroptosis. Curr Biol 26:R568–R572. https://doi.org/10.1016/j.cub.2016.02.019CrossRefPubMed

Wang Y et al (2017) Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547:99–103. https://doi.org/10.1038/nature22393CrossRefPubMed

Wang YY, Liu XL, Zhao R (2019) Induction of pyroptosis and its implications in cancer management. Front Oncol 9:971. https://doi.org/10.3389/fonc.2019.00971CrossRefPubMedPubMedCentral

Wang Q et al (2020a) A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature 579:421–426. https://doi.org/10.1038/s41586-020-2079-1CrossRefPubMed

Wang X et al (2020b) NLRP6 suppresses gastric cancer growth via GRP78 ubiquitination. Exp Cell Res 395:112177. https://doi.org/10.1016/j.yexcr.2020.112177CrossRefPubMed

Wei Q et al (2013) Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 94:52–62. https://doi.org/10.1038/labinvest.2013.126CrossRefPubMed

Wu D, Wang S, Yu G, Chen X (2021) Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew Chem Int Ed Engl 60:8018–8034. https://doi.org/10.1002/anie.202010281CrossRefPubMed

Xia X et al (2019) The role of pyroptosis in cancer: pro-cancer or pro-"host"? Cell Death Dis 10:650. https://doi.org/10.1038/s41419-019-1883-8CrossRefPubMedPubMedCentral

Ye Y, Dai Q, Qi H (2021) A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death Discov 7:71. https://doi.org/10.1038/s41420-021-00451-xCrossRefPubMedPubMedCentral

Yoshihara K et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https://doi.org/10.1038/ncomms3612CrossRefPubMed

Yu J et al (2019) Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis 10:193. https://doi.org/10.1038/s41419-019-1441-4CrossRefPubMedPubMedCentral

Zhang CC et al (2019) Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation. Apoptosis 24:312–325. https://doi.org/10.1007/s10495-019-01515-1CrossRefPubMed

Zhang Z et al (2020) Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579:415–420. https://doi.org/10.1038/s41586-020-2071-9CrossRefPubMedPubMedCentral

Zhou X et al (2020) Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma. J Hematol Oncol 13:77. https://doi.org/10.1186/s13045-020-00906-1CrossRefPubMedPubMedCentral

Titel: Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma
verfasst von: Liemei Lv
Yu Zhang
Ran Kong
Cong Wang
Xin Wang
Xiangxiang Zhou
Publikationsdatum: 15.07.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 14/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05018-0

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 14/2023

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization

Nomograms constructed for predicting diagnosis and prognosis in cervical cancer patients with second primary malignancies: a SEER database analysis

Identification of lactate-related subgroups and prognostic model in triple-negative breast cancer

A radiomics-clinical combined nomogram-based on non-enhanced CT for discriminating the risk stratification in GISTs

The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands

Neu im Fachgebiet Onkologie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Update Onkologie